Interpreting Adverse Signals in Diabetes Drug Development Programs

Por Bailey, Clifford J.
Publicado em 2013

Why is Exubera being withdrawn?

Por Bailey, Clifford J, Barnett, Anthony H
Publicado em 2007

Thiazolidinediones for type 2 diabetes : New agents reduce insulin resistance but need long term clinical trials

Por Krentz, Andrew J, Bailey, Clifford J, Melander, Arne
Publicado em 2000

Insulin-like effect of pinitol

Por Bates, Sarah H, Jones, Robert B, Bailey, Clifford J
Publicado em 2000

Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency

Por Lipska, Kasia J., Bailey, Clifford J., Inzucchi, Silvio E.
Publicado em 2011

Insulin-releasing action of the novel antidiabetic agent BTS 67 582

Por McClenaghan, Neville H, Flatt, Peter R, Bailey, Clifford J
Publicado em 1998

Metformin and the gastrointestinal tract

Por McCreight, Laura J., Bailey, Clifford J., Pearson, Ewan R.
Publicado no Diabetologia (2016)

Functional Enhancement of Electrofusion-derived BRIN-BD11 Insulin-secreting Cells After Implantation into Diabetic Mice

Por Davies, Emma L., Abdel-Wahab, Yasser H. A., Flatt, Peter R., Bailey, Clifford J.
Publicado em 2001

Antihyperglycaemic effect of saccharin in diabetic ob/ob mice

Por Bailey, Clifford J, Day, Caroline, Knapper, Jacqueline M E, Turner, Susan L, Flatt, Peter R
Publicado em 1996

Metformin in Patients With Type 2 Diabetes and Kidney Disease: A Systematic Review

Por Inzucchi, Silvio E., Lipska, Kasia J., Mayo, Helen, Bailey, Clifford J., McGuire, Darren K.
Publicado no JAMA (2014)

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

Por Bailey, Clifford J, Gross, Jorge L, Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A, List, James F
Publicado em 2013

Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

Por Bailey, Clifford J, Gross, Jorge L, Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A, List, James F
Publicado em 2013

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

Por Fouqueray, Pascale, Pirags, Valdis, Inzucchi, Silvio E., Bailey, Clifford J., Schernthaner, Guntram, Diamant, Michaela, Lebovitz, Harold E.
Publicado em 2013

The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenarios

Por McGill, Margaret, Blonde, Lawrence, Chan, Juliana C.N., Khunti, Kamlesh, Lavalle, Fernando J., Bailey, Clifford J.
Publicado no J Clin Transl Endocrinol (2016)

Enhanced cAMP generation and insulin-releasing potency of two novel Tyr1-modified enzyme-resistant forms of glucose-dependent insulinotropic polypeptide is associated with signific...

Por Gault, Victor A, Flatt, Peter R, Bailey, Clifford J, Harriott, Patrick, Greer, Brett, Mooney, Mark H, O'harte, Finbarr P M
Publicado em 2002

Plasma irisin levels predict telomere length in healthy adults

Por Rana, Karan S., Arif, Muhammad, Hill, Eric J., Aldred, Sarah, Nagel, David A., Nevill, Alan, Randeva, Harpal S., Bailey, Clifford J., Bellary, Srikanth, Brown, James E.
Publicado em 2014

Age‐associated changes in long‐chain fatty acid profile during healthy aging promote pro‐inflammatory monocyte polarization via PPARγ

Por Pararasa, Chathyan, Ikwuobe, John, Shigdar, Shahjahan, Boukouvalas, Alexis, Nabney, Ian T., Brown, James E., Devitt, Andrew, Bailey, Clifford J., Bennett, Stuart J., Griffiths, Helen R.
Publicado no Aging Cell (2015)

Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508

Por Home, Philip, Riddle, Matthew, Cefalu, William T., Bailey, Clifford J., Bretzel, Reinhard G., del Prato, Stefano, Leroith, Derek, Schernthaner, Guntram, van Gaal, Luc, Raz, Itamar
Publicado no Diabetes Care (2014)

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

Por Home, Philip, Riddle, Matthew, Cefalu, William T., Bailey, Clifford J., Bretzel, Reinhard G., del Prato, Stefano, Leroith, Derek, Schernthaner, Guntram, van Gaal, Luc, Raz, Itamar
Publicado no Diabetes Care (2014)